Phase II trial of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: 5-year clinical outcomes of a trial of the ECOG-ACRIN Cancer Research Group (E3204).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 3592-3592
Author(s):  
Jerome Carl Landry ◽  
Yang Feng ◽  
Roshan Sudhir Prabhu ◽  
Steven J. Cohen ◽  
Charles A. Staley ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Cancer Research ◽  
Clinical Outcomes ◽  
Phase Ii ◽  
Research Group ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer ◽  
Preoperative Radiation

A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3771-3771 ◽  
Author(s):  
S. J. Wong ◽  
C. Sadasiwan ◽  
B. Erickson ◽  
D. Ota ◽  
D. Mulkerin ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer
Sign in / Sign up

Export Citation Format

Share Document